People on the move
Sinclair Research has created a new role at the company, naming Alex Wakefield as vice president of research and operations.
In this role, Wakefield will be responsible for the company’s research services and its operational processes.
“Sinclair Research has distinguished itself through the successful development of many unique animal models, and has recently experienced significant growth in its GLP programs in both IND enabling toxicology and efficacy models,” said Wakefield.
“The company is poised for further growth and I am excited to have the opportunity to leverage my experience with large drug development programs to help Sinclair reach its full potential,” he told us.
Wakefield joins the preclinical CRO from Covance, where he worked in areas including discovery science, toxicology, veterinary services, business development, and management. He has held similar positions at Eli Lilly and Company.